Clinical Trials Directory

Trials / Completed

CompletedNCT03543982

Effects of Oral Probiotic Product on Vaginal Microbial Community and Parameters of Vaginal Health

An Open-label, Pilot Study to Assess the Effects of an Oral Probiotic Product on the Vaginal Microbial Community and on Parameters of Vaginal Health

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
37 (actual)
Sponsor
UAS Labs LLC · Industry
Sex
Female
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

The purpose of the study is to assess the efficacy and safety of an oral probiotic product on the vaginal microbiome and on parameters of vaginal health. Eligible subjects will utilize the investigational product as directed for a period of 28 days. The vaginal microbial community and parameters of vaginal health will be measured at baseline and after 14 and 28 days of supplementation. A follow-up post-supplementation visit will be conducted on Day 42.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTOral probiotic productOnce per day (QD), 28 days

Timeline

Start date
2018-05-23
Primary completion
2020-10-01
Completion
2021-03-18
First posted
2018-06-01
Last updated
2021-04-08

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT03543982. Inclusion in this directory is not an endorsement.

Effects of Oral Probiotic Product on Vaginal Microbial Community and Parameters of Vaginal Health (NCT03543982) · Clinical Trials Directory